Evaluation of adherence to therapy in patients of chronic kidney disease

被引:27
|
作者
Sontakke, Smita [1 ]
Budania, Ritu [1 ]
Bajait, Chaitali [1 ]
Jaiswal, Kavita [1 ]
Pimpalkhute, Sonali [1 ]
机构
[1] Govt Med Coll, Dept Pharmacol, Nagpur, Maharashtra, India
关键词
Medication nonadherence; morisky medication adherence questionnaire; polypharmacy in chronic kidney disease; MEDICATION; HEMODIALYSIS; PATTERNS;
D O I
10.4103/0253-7613.169597
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To evaluate adherence to medication and study factors associated with non-adherence in chronic kidney disease (CKD) patients. Methods: A prospective, cross-sectional, questionnaire based study was conducted in Nephrology department of a super specialty hospital. Patients above 18 years of age, suffering from CKD from six months or more were interviewed using self-designed, semi-structured questionnaire to get information about adherence to medication, diet restriction and lifestyle modification (n = 150). Morisky medication adherence questionnaire was used to calculate overall adherence. In this higher score indicates poor adherence. Main outcome measures included prevalence of non-adherence and factors associated with the same. Results: Average number of medicines taken by each patient was 8.0+1.612 (mean+SD) per day. Non-adherence to medication schedule was reported in 34% patients. Common causes of non-adherence were high cost (21.3%), complex dosing schedule (20%), fear of adverse effects (16%). Sixty-eight% patients were not aware about importance of taking each medicine. Sixteen% stopped taking medicines due to high cost. Forty-two% suggested that government should adopt measures to provide free medicines to poor patients. In Morisky medication adherence questionnaire high, medium and low adherence was reported in 7.3%, 55.3% and 37.3% of patients, respectively. Moderately positive correlation was observed between poor adherence and number of concurrent illnesses and number of medicines taken. Conclusion: Since majority of patients were not aware about importance of taking each medicine, creating awareness about the same is essential for improving adherence to therapy. Measures to provide free medicines to non-affording patients need to be implemented since high cost was other major cause of non-adherence.
引用
收藏
页码:668 / 671
页数:4
相关论文
共 50 条
  • [41] Impact of Intensified Pharmaceutical Interventions in Medication Adherence in Chronic Kidney Disease Patients
    Chandrasekhar, Dilip
    Ganesan, V. M.
    Sreekumar, Sreelekha
    Pradeep, Anuja
    Geoji, Asha Susan
    George, Athira Elezabath
    Athira, V
    JOURNAL OF YOUNG PHARMACISTS, 2018, 10 (02) : 208 - 212
  • [42] Illness perception, coping and adherence to treatment among patients with chronic kidney disease
    Velez-Velez, Esperanza
    Bosch, Ricardo J.
    JOURNAL OF ADVANCED NURSING, 2016, 72 (04) : 849 - 863
  • [43] Medication regimen complexity and medication adherence in elderly patients with chronic kidney disease
    Parker, Krystina
    Bull-Engelstad, Ingrid
    Aasebo, Willy
    von der Lippe, Nanna
    Reier-Nilsen, Morten
    Os, Ingrid
    Stavem, Knut
    HEMODIALYSIS INTERNATIONAL, 2019, 23 (03) : 333 - 342
  • [44] A snapshot of European registries on chronic kidney disease patients not on kidney replacement therapy
    Jager, Kitty J.
    Asberg, Anders
    Collart, Frederic
    Couchoud, Cecile
    Evans, Marie
    Finne, Patrik
    Peride, Ileana
    Rychlik, Ivan
    Massy, Ziad A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (01) : 8 - 13
  • [45] Cardiac Device Therapy in Patients with Chronic Kidney Disease: An Update
    Caba, Bogdan
    Vasiliu, Laura
    Covic, Maria Alexandra
    Sascau, Radu
    Statescu, Cristian
    Covic, Adrian
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [46] Resveratrol: Why Is It a Promising Therapy for Chronic Kidney Disease Patients?
    Saldanha, Juliana F.
    Leal, Viviane de O.
    Stenvinkel, Peter
    Carraro-Eduardo, Jose Carlos
    Mafra, Denise
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2013, 2013
  • [47] STATIN THERAPY IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING HAEMODIALYSIS
    Strapcane, Santa
    Petersons, Aivars
    Skride, Andris
    Kigitovica, Dana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1211 - I1211
  • [48] Hypertension Control and Antihypertensive Therapy in Patients With Chronic Kidney Disease
    Unni, Sudhir
    White, Kellee
    Goodman, Michael
    Ye, Xiangyang
    Mavros, Panagiotis
    Bash, Lori D.
    Brixner, Diana
    AMERICAN JOURNAL OF HYPERTENSION, 2015, 28 (06) : 814 - 822
  • [49] Is There a Role for Diaphoresis Therapy for Advanced Chronic Kidney Disease Patients?
    Hanafusa, Norio
    Lodebo, Bereket Tessema
    Shah, Anuja
    Kopple, Joel D.
    JOURNAL OF RENAL NUTRITION, 2017, 27 (05) : 295 - 302
  • [50] Device Therapy in Heart Failure Patients With Chronic Kidney Disease
    Badheka, Apurva
    Rathod, Ankit
    Tuliani, Tushar
    Afonso, Luis
    Jacob, Sony
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (05) : 542 - 543